Despite over 61,000 new episodes presenting to genitourinary medicine (GUM) clinics in England in 1992-3, few diseases in GUM have remained as elusive to both clinician and researchers, nor taxed the patience of editors as non-gonococcal urethritis (NGU). Recent understanding of the pathophysiology of chlamydial infection and widespread availability of non-culture methods for the detection of Chlamydia trachomatis, including polymerase chain reaction (peR), has provided evidence for the hypothesis that damage caused by e. trachomatis may in part be through the immunological response of the body either to persisting chlamydial antigens or through cross-reacting immunity with tissue antigens. Although most of this information has come from studies of the eye, the fallopian tubes and the joints and their relevance to the pathophysiology of NGU remains to be determined, clinical and experimental data exists to suggest that similar mechanisms may be operating there.
INTRODUCTION
Despite over 61,000 new episodes presenting to genitourinary medicine (GUM) clinics in England in 1992-3, few diseases in GUM have remained as elusive to both clinician and researchers, nor taxed the patience of editors as non-gonococcal urethritis (NGU). Recent understanding of the pathophysiology of chlamydial infection and widespread availability of non-culture methods for the detection of Chlamydia trachomatis, including polymerase chain reaction (peR), has provided evidence for the hypothesis that damage caused by e. trachomatis may in part be through the immunological response of the body either to persisting chlamydial antigens or through cross-reacting immunity with tissue antigens. Although most of this information has come from studies of the eye, the fallopian tubes and the joints and their relevance to the pathophysiology of NGU remains to be determined, clinical and experimental data exists to suggest that similar mechanisms may be operating there.
This paper briefly reviews our current understanding of the pathophysiology of infections with e. trachomatis and its possible relevance to NGU and on fertility. The microbiology of NGU will be discussed and a brief outline of the bewildering variety of non-culture tests for chlamydia will be presented. Rather than providing answers to the many questions raised by this condition, this review attempts to set out some of the questions that could be asked.
.
ORGANISMS
Infection by e. trachomatis accounts for 30-60% of cases of NGUl-3, and is more likely to be isolated in first than subsequent attacks of urethritis. Alani! isolated chlamydia by culture from 55.6% and 51.4% in first and second attack of NCU respectively but only in 12% of subsequent attacks. Although the number of patients in the last group was small, similar results have been reported by others'. Hay et al. 5 examined both the urethral exudate and the first pass urine by a variety of assays, including polymerase chain reaction (PCR), and found 49% of 112 men with urethritis to be positive for e. irachomatie. Assuming that the assays picked up most if not all the chlamydia, the rest were presumed to be chlamydia-negative NGU. Rahman et al. 6 using a hybridization assay directed against chlamydial RNA in a small number of patients attending an STD clinic suggested that standard culture and direct immunofluorescence (DFA) techniques may be missing a significant number of inapparent infections. However, it is reasonable to assume that while current assay systems may be missing a certain number of chlamydia-positive NGU, this microorganism cannot explain all cases of chlamydia-negative NCU.
e. trachomatis has also been isolated in 3%-25% of asymptomatic men 5,7-15. Asymptomatic infection appears to be more common in younger men 16 and is related to the infective dose as judged by the number of inclusion bodies in the urethral exudatel". significantly more frequently from chlamydianegative (35%) than chlamydia-positive (7%) NGU patients. As the authors only enquired as to the number of sexual partners in the month previous to presentation at the clinic, this difference could merely reflect differing levels of sexual activity between the groups. Similar results were, however, reported by Homer etaI. 29 who found that either M. genitalium or chlamydia was more likelyto be isolated from urethral swabs of patients with symptomatic NGU than from controls. There was no difference between mycoplasma-positive and control groups with regards to the proportion who had changed sexual partners in the preceding 3 months. Any conclusion however has to be cautious since numbers were small and the authors also reported that the urethritis group as a whole (as well as those with chlamydia-positive urethritis) had significantly higher partner change in the preceding 3 months than controls. Moreover, even o~a modified Henle-Koch criteria,24 M. genitalium fails to fulfil such criteria as a rise in antibody titre and disappearance of the disease on eradication of the organism after appropriate antimicrobial therapy to be conclusively identified as a cause of chlamydianegative NGU. The organism may, however, be a causative agent in some cases of NGU.
Other organisms suggested are Bacteroides urealyticus 30 though WOOlley31 showed that the org~nism was no more prevalent in urethritis patients than in controls. Neisseria meningitides has been found to be infrequently associated with urethritis in homosexual men. Maini et aI.32 and M~Ken~a33found isolation rates of non-gonococcal neissena to be 30 times higher in homosexual compared to heterosexual men but was associated with urethritis in only a few. N. meningitides has also been isolated from the urethra of heterosexual meñ ith NGU34, though its relevance to the Inflammatory process remains conjectural.
eduction in recurrence rate in the male patient WIth NGU when chlamydia negative female partners were given epidemiological treatment has been used as evidence for an infective aetiology of chlamydia-negative NGU35. Non-gonococcal ethritis can be associated with other genitourinary Infect~ons. Female partners of men with chlamydianeg~tIve urethritis were more likely to have a g~n~tourinary infection than those without". SImilarly male partners of women with bacterial vaginosis were more likel t to have NGU than partners of women without 7. As will be discussed below other genitourinary infections may cause NGU indirectly by triggering an inflammatory response in an already primed urethra.
PATHOGENESIS
Recurrence and persistence of NGU has long taxed the endurance of genitourinary physicians and Lomas et aI.39 used a neutrophil chemoattractant assay to investigate the inflammatory stimulus in the urethras of men with NGU before and after standard treatment. Men with chlamydia-negative urethritis, whether they had been sexually exposed or not, showed a high level of chemotactic activity which was not significantly lowered by therapy. In contrast patients with chlamydia-positive urethritis had a significant fall in neutrophil chemotactic activity after therapy which increased to pretreatment levels within 2 weeks in the absence of a history or evidence of reinfection. Moreover, a similarly high level of chemotactic activity persisted in those patients returning for follow up for 6 months without a history of sexual exposure. Interestingly, at no stage after the onset of urethritis did chemotactic activity return to control levels suggesting a heightened inflammatory stimulus in the urethra after chlamydia-positive and chlamydianegative urethritis, The stimulus for this persistent inflammation remains conjectural as is the nature of chlamydia negative urethritis in which no microorganism is isolated. We will review the available evidence for the pathogenesis of chlamydia positive and negative urethritis separately.
Chlamydia trachomatis urethritis
There is mounting evidence that the damage (blindness, fallopian tube blockage, arthritis) which may follow infection with chlamydia is mediated through immunological mechanisms 40 -44 • A similar process to that occurring in the eye or fallopian tube may be operating in the urethras". Animalmodels suggest that protection against chlamydia infection is predominantly T-cell dependent I6 ,46,47. Cellular immunity may also be responsible for the immune damage 44 which can take place in the absence of any symptomsw.
There are two ways of viewing the pathological process causing persistent inflammation in the urethra, as well as non-genitourinary sites, following infection with C. trachomatis. The first postulates that chlamydia, either as the whole organism or in an incomplete form, may persist in tissues and provokes an immune response. Alternatively, challenge by chlamydia in a susceptible individual could provoke an immunological response which causes tissue damage by recognizing crossreactive antigens in the tissue. The available evidence to date is insufficient to allow conclusion as to which mechanism is dominant. It is possible to postulate that similar immune mechanisms may also underlie some cases of acute chlamydia-negative urethritis.
Since in adults the exact timing of genital chlamydial infection is difficult to ascertain with any confidence, evidence for persistence of infection with chlamydia in vivo has mainly come from children presumably infected during birth. Goh and Forster in a recent review of the literature reported that chlamydia antigen may persist for up to 31ears in children thought to be infected at birth 4 and antis §"en has even been isolated in a 6-year old girl . Chlamydia was isolated one year after birth in 35% of children infected at birth from the conjunctiva and nasopharynx'". Current detection techniques may also lack the necessary sensitivity and persistence in small numbers, particularly in protected sites, cannot be excluded in infected individuals after apparent clearing of the infection.
Indeed, more sensitive detection techniques have increased the pick-up rate of C. trachomatis in NGU 52 • One possible site suggested as a reservoir for persisting chlamydial infection in men with recurrent urethritis is the prostate gland 53, though it is unclear from that study what precautions were taken to prevent re-infection by the untreated sexual partner. The monocyte-macrophage system could also act as a reservoir (see below). Chlamydia may also persist in tissues as a nonproductive infection or in an incomplete form 54. Although in women chlamydia cannot be isolated by culture or enzyme-linked immunosorbent assay (ELISA) for up to 5 weeks follow up after conventional therapy55,56 it is possible that antibiotic treatment may render chlamydia non-infectious or non-cultivable yet capable of surviving for long periods and providing an immunological stimulus in some tissues. Non-infectious forms have been demonstrated in vitro when certain metabolic stresses are applied to the organism such as deprivation of tryptophan and other specific amino acids, treatment with penicillin or when the physical environment is changedv". There is also evidence that gamma interferon and other cytokines 58 , as well as the infective dose 59 affect the growth and persistence of chlamydiae in vitro. In vitro doses of gamma interferon that are similar to those achieved in cervical secretions and serum of women with chlamydial cervicitis result in persistent infection characterized by non-infectious atypical chlamydial forms from which infectious progeny could be recovered when interferon is removed from the cultures 60 • Interferon may have this effect by acting on infected cells to deprive chlamydia of tryptopharr". It is possible that conditions normally encountered in vivo will also be stressful to chlamydia resulting in the emergence of noncultivable forms of the organism.
Chlamydial antigens and nucleic acids have been identified at some non-genitourinary sites, though whether or not intact organism can be found in such sites remains controversial (reviewed in 42). In monkeys'S C. trachomatis RNA and DNA can be present and cause ocular inflammation in a culturenegative state. Chlamydial antigen (ELISA) and DNA (PCR) were more likely to be detected in patients with trachoma and scarring than in controls 63 • Chlamydial antigens 64 77 also identified T-cell epitopes in MOMP which is a target for a primary T-cell response in 80% of chlamydia-naive human volunteers, and even from cells obtained from cord blood. Delayed type hypersensitivity to MOMP may be a mechanism through which the immunopathology of chlamydia operates". In a recent study Holland et al. 63 showed that the conjunctival scarring caused by C. trachomatis appears to be associated with persistence of chlamydial antigen, a reduced cell mediated immunity to specific chlamydial antigens and an enhanced antibody response to chlamydia.
An alternative explanation for the damage resulting from chlamydial infections is to invoke an immunological mechanism whereby challenge by C. trachomaiis in a susceptible individual gives rise to a population of immunocytes which can cause tissue-specificdamage-either by homing on tissues such as joints, fallopian tubes, conjunctivae, or possibly urethral mucosa, or recognizing crossreacting antigens that happen to be there. One such candidate is the chlamydial heat shock proteins (hsp). The chlamydial 57-kDa protein has been identified as a member of the 6O-kDa hsp family. These proteins are predominant antigens of many pathogenic bacteria. There is significant homology between the chlamydial57-kDa hsp and the human 60-kDa hsp79. Interestingly the chlamydial57-kDa hsp is not only produced at increased levels during the intracellular stage of the infection, but also during non-productive infections 60 86 showed that PBMC from women with laparoscopically proven salpingitis showed proliferative response to a recombinant C. tra~homatis 57-kDa hsp.~t he role of antibodies in protecting against reinfection by chlamydia remains to be defined, and may be only transient 16 , 59 , there is evidence that in the eye the production of antibody to certain antichlamydia! vaccines may have a role in the damage caused by re-exposure to chlamydia'". The serum antibody level also appears to correlate with the damafe in fallopian tubes in women 88 , infertility in men 1 and scarring in the eye 63 • There is evidence that chlamydia activates the alternative complement pathway and the recently reported mimicry between the 40 kDa MOMP protein and C3b 89 suggests that complement may also be involved in the tissue damage.
Chlamydia-specific IgG secreting B cellshave been found in cervical lymph nodes after challenge of unmune monkeys with chlamydial 57-kDa hSp90. There are also B cell peptide epitopes in chlamydia 6O-kDa hsp which showed common epitopes in rabbits and in women with chlamydia! associated ectopic pregnancy suggesting self reactive immunity to 6O-kDa h sp 79. In summary the evidence points to an immunological mechanism for the damage resulting from infection by C. trachomatis in the eye, joint and fallopian tube. The availabledata cannot distinguish hether the damage is caused by a persisting infectionor by stimulation of cross reacting antigens.
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Most of the evidence points to the central role of antigen-specific T-cell response. Tissue damage appears also to be associated with enhanced antibody production to C. trachomatis.
Chlamydia negative urethritis
Conventional therapy of NGU with tetracycline or erythromycin in the absence of demonstrable infection with C. trachomatis and U. urealyticum therapy is less effective and relapse is more likely91 suggesting either an as yet unidentified microorganism less responsive to standard NGU therapy or a non-infective inflammatory process. However, Hooton showed that a 3-week course of erythromycin can successfully eradicate the signs of NGu9 2 though this may have been in part the result of the anti-inflammatory properties of erythromycin's. While usually asymptomatic in the male, T. vaginalis occasionally causes urethritis, particularly in Afro-Caribbeans, and would not respond to tetracyclines or erythromycin's. Failure of anti-inflammatory drugs such as ibuprofen, prostaglandin El and corticosteroids, however, to prevent tissue damage in animal models of salpingitis'" and in limited studies in men with NGU2S appears to contradict an immunological mechanism. However, Marcovici et aI. 96 have demonstrated a dear inhibition of the fibrosisin chlamydia-induced fallopian tube damage by colchicine in animals. Trialsin humans, including men with recurrent NGU might prove helpful. There is also some animal data on the role of the beta adrenergic nervous s~stem on the inflammatory process in the urethra . The study showed that the use of beta-2-adrenergic receptor antagonists significantly reduced experimentally induced urethral inflammation in the rat.
There is increasing animal experimental evidence for the existence of 2 populations of T-helper cells distinguished by different eytokine release. T-helper 1 (TH-l) cells secrete gamma interferon, tumour necrosis factor and interleukin (IL)-2 and are involved in delayed-type hypersensitivity. TH-2 cells secrete IL-4, IL-5 f and IL-l0 and modulate Bcell antibody production's. A unifying hypothesis to explain damage caused by chlamydia as well as some cases of chlamydia-negative NGU might postulate that in some patients a defective TH-l response and preferential activation of a TH-2 response results in ineffective delayed hypersensitivity response to C. trachomaiis. This could result in reduced gamma interferon production and a consequent inability to clear C. trachomatis from tissues. The inflammatory response may be provoked by the persistence of chlamydia in tissues or through production of antigens with significant homology with host antigens (such as heat shock proteins). The activation of TH2 type response can itself cause damage through antibodies, with or without complement mediation. In the urethra this process can cause a persisting inflammatory process'? which may be reactivated by organisms which do not normally cause a urethritis such as anaerobic bacteria, ureaplasma, bacteroides etc. The finding of a high prevalence of NGU in contacts of women with a variet~of genital infection'" or with bacterial vaginosis 7 appears to support this hypothesis. Similarly NGU following orogenital contact'? may have a similar aetiology. Other evidence for a reactive urethritis comes from another source. Reactive arthritis secondary to gastrointestinal infections by organisms such as Yersinia and Salmonella is not infrequently associated with urethritis100•
EFFECT ON FERTILITY
The major role played by C. trachomatis in infertility in the female on a global scale is outside the scope of this article. Little is known of the effect of NGU on fertility in the male!". Men with unexplained infertility were more likely to have anti-chlamydial antibody at a titre of 1:64 or higher than first time expectant fathersl?'. This study however, did not look at anti-chlamydial antibodies in the female partner. A recent review has summarized current knowledge on the effect of infection of the male genital tract on fertility102.
Witkins et al. 103 trachomatis was detected by PCR. Shahmanesh, using chlamydia culture has shown that serum anti-sperm antibodies are more prevalent in patients infected with chlamydia than controls and that in a minority anti-sperm antibodies can be shown to rise during urethral infection with chlamydia'Pt, Wolff 106 showed a raised PMNelastase activity in seminal plasma of men with C. trachomatis antibodies in their semen which was associated with poor sperm motility, volume, and citric acid content. Clearly much work needs to be done to clarify the role of chlamydial infections in male infertility.
WHICH TESTS?
NGU is diagnosed by the presence of 5 or more PMN per oil immersion field (x 1(00)18 or 15 or more PMN in any 5 random fields (x 400) of the sediment of the first voided urine 107 • The differentiation of infective and non-infective causes of an inflammation is not helped by the simple, but at times misleading use of the actual inflammatory exudate (PMN content) of urethral secretions as a surrogate marker for infection. This introduces both a large laboratory error (intra-and inter-observer error)l08and a conceptual error (inflammations are not always directly the result of infection). It is therefore logical to move towards a microbiological diagnosis, though the questions regarding the role, if any, of non-chlamydial microorganisms in those in whom chlamydia cannot be found even by the most sensitive assay means that we would need to continue to measure the inflammatory process in association with chlamydia assays. However, in formulating therapy, particularly repeated courses of antibiotics, the limitations of the urethral Gramstain needs to be constantly born in mind.
Tests for the microorganisms associated with NGU other than C. tmchomatis will not be discussed in this article. A virtual epidemic of non-culture tests for chlamydia present the clinicianwith a bewildering choice. Recent reviews summarize the dilemma 1 d § and guide the weary or unwary clinician over this minefield llO ,l11 . While the sensitivity of culture can be increased by a second passage and culture remains the only proof that we are dealing with a living organism, the possible role of small number of infective particles as well as non-cultivable forms of the organism in the pathogenesis of NGU makes the use of the culture as gold standard for the evaluation of newer assays problematic'w. Not surprisingly sensitivity and specificity of in vitro assays are related to the number of infective particles in the specimen'P, and positive and negative predictive value will vary with the prevalence of C. trachomatis infectionin the population studied'", Reports from high prevalence populations may not apply to low prevalence populations. This is not only because in low prevalence settings false positive/negative test results will be proportionately higher, but also because there may be quantitative% less antigen in genital secretions in these settings! and during asymptomatic infectiontt-. Assays would therefore have to be validated in the different populations studied. False positive and negative results can be lessened by using confirmatory tests using such as blockinr. antibodies 113 -116 or direct immunofluorescence'! -117. Confirmatory tests are mandatory in low prevalence settings, and preferable in other populations'P". Use of non-culture techniquesglus confirmation l 14 , 115 or by amplification assays suggests that culture may miss some cases of C. trachomatis infection.
A novel approach to ensure specificity and sensitivity is to use a monoclonal anti-idiotypic antibody directed against a chlamydia-specific epitope on 60 kDa hsp. This relies on the competitive binding of chlamydia hsp which is released even by non-cultivable C. trachomatis 118 • Sensitive and specific chemiluminescent assays have also been reported 119.120 • DNA hybridization commercially available as Gene-Probe Pace 2 C. trachomatis, in women is a good alternative to culture 121, but needs further evaluation in men-l", The availability of nucleic acid amplification techniques (PCR) to detect hlamydia DNA and RNA have the advantage of mcreased sensitivity and specificity, but need great care in interpretation because of the problem of Contamination.
hlamydia PCR have been developed with pnmers directed against a number of targets, mcluding an invariably present endogenous plasmid, a conserved region of the MOMP gene and a 16s ribosomal RNA gene. A comparison between these primers in cervica}122 and urethral samples 123 sho~~d that the plasmid primer is the most SenSItIve. PCR can also act as confirmatory test and may be superior to enzyme immunoassay (BIA) plus a blocking reagent 124 for this task. PCR is more sensitive than culture 125,126 and probably the most sensitive of the in vitro tests 111 ,f27. Because of the amplification procedure PCR assays are extremely pron~to contamination and 'carry over' from preVIOUS positive samples. Thus PCR positive, cUlt~re-negative specimens would need to be confirmed by using ELISA or Immunofluore~cence124,128, a second rca directed against different targets 124 or the same target using a S~cond 'pair of primers that were nested within the first parr 129 to improve specificity.
PCR and all non-culture tests have the disadvantage of not distinguishing active infection fro~latent infection or the presence of chlamydia antigen without the whole organism. Thus PCR can remain positive for up to 3 weeks after the start of dOxycycline therapy in females with cervical chlamydia 122, However, as discussed above, ncultivableforms of C. trachomatis may playa role in the production of the tissue damage caused by th~or~anism, although the role, if any, of antimIcrobIal therapy in this situation remains to be determined. Moreover, PCR can be used to detect C. trachomatis in cryopreserved donor sperms which had previously given negative results by cell CUlture 130, or even in archive microscopy slides 131, Lack of sensitivity16.132 and presence of cross re~c~in~antibodies to C. pneumoniae and C.
PStt~tcil severely limit the use of anti-chlamydial antIbodies for diagnostic purposes. Others have
Suggested that measurement of anti-ehlamydial 19Ã
ay be useful for laboratories with poor microbIolOgical back up134,l35.
Availability of sensitive and specific non-culture assays on urine 5,12,28,116 including asymptomatic men 15 , l 36 not only provides long awaited relief for the male urethra in patients attending genitourinary Shahmanesh . Problems with non-gonococcal urethritis 395 clinics but opens the way to large epidemiological studies. A further advantage of urine is that, unlike urethral swabs, the time since last voiding of urine appears to have little effect in the antigen detection assays137. Others have questioned whether urine samples can replace urethral swabs for the laboratory diagnosis of chlamydial urethritis in the male l 38 • Prior screening of urine with a leucocyte esterase strip can allow the selection of samples for further infection testing 139. Polymerase chain reaction 124,140 and chemoluminometric assaysl20 can also be used on urine samples, even in asymptomatic men. A rapid colorimetric PCR was used on urine samples in which the chlamydia was ingeniously concentrated using antibodies attached to magnetsw'. CONCLUSION C. trachomatis is the single most common infection associated with NGU and causes an inflammatory response which persists even after the organism has been apparently eradicated with standard antimicrobial therapy. Evidence from chlamydia! infection in other tissues suggests that chlamydial infections may trigger a prolonged inflammatory process either through the persistence of chlamydial antigens or through cross reacting immunity with tissue antigens with significant homology with host antigens, such as heat shock proteins. Similar immunological mechanisms may be operating in the clinical and subclinical persistence of urethritis after C. trachomatis infection, may contribute to some cases of male infertility and may also explain some cases of chlamydia-negative NGV. The use of more sensitive assays, such as PCR, may also define a further group of patients where conventional assay methods could have missed infection with C.
trachomatis.
Research into the qualitative and quantitative cellmediated immune response to chlamydia! antigens of peripheral blood T lymphocytes as well as lymphocytes obtained from the urethral exudate in patients with acute as well as recurrent or persistent urethritis may help to elucidate the aetiology of some cases of chlamydia-negative or persistent NGD. 
